Loading…
Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations
A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity w...
Saved in:
Published in: | Indian journal of pharmaceutical sciences 2011-11, Vol.73 (6), p.693-696 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83 |
---|---|
cites | |
container_end_page | 696 |
container_issue | 6 |
container_start_page | 693 |
container_title | Indian journal of pharmaceutical sciences |
container_volume | 73 |
creator | Pradhan, K K Mishra, U S Pattnaik, S Panda, C K Sahu, K C |
description | A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan. |
doi_str_mv | 10.4103/0250-474X.100254 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A301924562</galeid><sourcerecordid>A301924562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</originalsourceid><addsrcrecordid>eNptUs9vFCEYJUZj1-rdkyHx4mVWfs4wF5O62takxkNt440wwGypDExhpkn_e9nduraNcIDwvffI974HwFuMlgwj-hERjirWsF9LjMqdPQML3Laiog2jz8FiXz4Ar3K-Roi2hDYvwQGhGBOGxALMX-yt9XEcbJigCgZeKu-MmlwMMPZQwfNJdc676a5ywThdKmENLy7h-Wj1lGLWcXQafrfTVTSwjwmuiorNKk0qQBfg59n_3gofxzTMfqucX4MXvfLZvrk_D8HF8defq9Pq7MfJt9XRWaVZi6dKd4RQxAnhWjDLUFkGaYQFNrytEVV123Wssw3RmIm659gqrDpcNw3pjRb0EHza6Y5zN1ijS5NJeTkmN6h0J6Ny8nEluCu5jreSMoEa3haBD_cCKd7MNk9ycFlb71Wwcc6y2MgJb4hABfr-CfQ6zimU9mQZlRBb8_-h1spb6UIfy796IyqPKMItYbwmBbX8D6psYwenY7C9K--PCGhH0GUkOdl-3yNGchMVucmC3GRB7qJSKO8eerMn_M0G_QOvC7hx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1038803923</pqid></control><display><type>article</type><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><source>Open Access: PubMed Central</source><creator>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</creator><creatorcontrib>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</creatorcontrib><description>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</description><identifier>ISSN: 0250-474X</identifier><identifier>EISSN: 1998-3743</identifier><identifier>DOI: 10.4103/0250-474X.100254</identifier><identifier>PMID: 23112408</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Analysis ; Candesartan ; Drug stability ; Methodology ; Pharmaceuticals ; Pharmacology ; Pharmacology, Experimental ; Short Communications ; Testing</subject><ispartof>Indian journal of pharmaceutical sciences, 2011-11, Vol.73 (6), p.693-696</ispartof><rights>COPYRIGHT 2011 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Apr 2011</rights><rights>Copyright: © Indian Journal of Pharmaceutical Sciences 2011</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480759/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480759/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23112408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pradhan, K K</creatorcontrib><creatorcontrib>Mishra, U S</creatorcontrib><creatorcontrib>Pattnaik, S</creatorcontrib><creatorcontrib>Panda, C K</creatorcontrib><creatorcontrib>Sahu, K C</creatorcontrib><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><title>Indian journal of pharmaceutical sciences</title><addtitle>Indian J Pharm Sci</addtitle><description>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</description><subject>Analysis</subject><subject>Candesartan</subject><subject>Drug stability</subject><subject>Methodology</subject><subject>Pharmaceuticals</subject><subject>Pharmacology</subject><subject>Pharmacology, Experimental</subject><subject>Short Communications</subject><subject>Testing</subject><issn>0250-474X</issn><issn>1998-3743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptUs9vFCEYJUZj1-rdkyHx4mVWfs4wF5O62takxkNt440wwGypDExhpkn_e9nduraNcIDwvffI974HwFuMlgwj-hERjirWsF9LjMqdPQML3Laiog2jz8FiXz4Ar3K-Roi2hDYvwQGhGBOGxALMX-yt9XEcbJigCgZeKu-MmlwMMPZQwfNJdc676a5ywThdKmENLy7h-Wj1lGLWcXQafrfTVTSwjwmuiorNKk0qQBfg59n_3gofxzTMfqucX4MXvfLZvrk_D8HF8defq9Pq7MfJt9XRWaVZi6dKd4RQxAnhWjDLUFkGaYQFNrytEVV123Wssw3RmIm659gqrDpcNw3pjRb0EHza6Y5zN1ijS5NJeTkmN6h0J6Ny8nEluCu5jreSMoEa3haBD_cCKd7MNk9ycFlb71Wwcc6y2MgJb4hABfr-CfQ6zimU9mQZlRBb8_-h1spb6UIfy796IyqPKMItYbwmBbX8D6psYwenY7C9K--PCGhH0GUkOdl-3yNGchMVucmC3GRB7qJSKO8eerMn_M0G_QOvC7hx</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Pradhan, K K</creator><creator>Mishra, U S</creator><creator>Pattnaik, S</creator><creator>Panda, C K</creator><creator>Sahu, K C</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20111101</creationdate><title>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</title><author>Pradhan, K K ; Mishra, U S ; Pattnaik, S ; Panda, C K ; Sahu, K C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Analysis</topic><topic>Candesartan</topic><topic>Drug stability</topic><topic>Methodology</topic><topic>Pharmaceuticals</topic><topic>Pharmacology</topic><topic>Pharmacology, Experimental</topic><topic>Short Communications</topic><topic>Testing</topic><toplevel>online_resources</toplevel><creatorcontrib>Pradhan, K K</creatorcontrib><creatorcontrib>Mishra, U S</creatorcontrib><creatorcontrib>Pattnaik, S</creatorcontrib><creatorcontrib>Panda, C K</creatorcontrib><creatorcontrib>Sahu, K C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pradhan, K K</au><au>Mishra, U S</au><au>Pattnaik, S</au><au>Panda, C K</au><au>Sahu, K C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations</atitle><jtitle>Indian journal of pharmaceutical sciences</jtitle><addtitle>Indian J Pharm Sci</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>73</volume><issue>6</issue><spage>693</spage><epage>696</epage><pages>693-696</pages><issn>0250-474X</issn><eissn>1998-3743</eissn><abstract>A simple, specific, accurate and stability-indicating UV- Spectrophotometric method was developed for the estimation of candesartan cilexitil, using a Shimadzu, model 1700 spectrophotometer and a mobile phase composed of methanol: water in the ratio of 9:1 at wave length (λ(max)) 254 nm. Linearity was established for candesartan in the range of 10-90 μg/ml. The percentage recovery of was found to be in the range of 99.76-100.79%. The drug was subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, UV light and photolytic degradation. Validation experiments performed to demonstrate system suitability, specificity, precision, linearity, accuracy, interday assay, intraday assay, robustness, ruggedness, LOD, and LOQ. While estimating the commercial formulation there was no interference of excipients and other additives. Hence this method can be used for routine determination of candesartan cilexetil in bulk and their pharmaceutical dosage forms. The proposed method for stability study shows that there was appreciable degradation found in stress condition of candesartan.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>23112408</pmid><doi>10.4103/0250-474X.100254</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0250-474X |
ispartof | Indian journal of pharmaceutical sciences, 2011-11, Vol.73 (6), p.693-696 |
issn | 0250-474X 1998-3743 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480759 |
source | Open Access: PubMed Central |
subjects | Analysis Candesartan Drug stability Methodology Pharmaceuticals Pharmacology Pharmacology, Experimental Short Communications Testing |
title | Development and Validation of a Stability-indicating UV Spectroscopic Method for Candesartan in Bulk and Formulations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A36%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Validation%20of%20a%20Stability-indicating%20UV%20Spectroscopic%20Method%20for%20Candesartan%20in%20Bulk%20and%20Formulations&rft.jtitle=Indian%20journal%20of%20pharmaceutical%20sciences&rft.au=Pradhan,%20K%20K&rft.date=2011-11-01&rft.volume=73&rft.issue=6&rft.spage=693&rft.epage=696&rft.pages=693-696&rft.issn=0250-474X&rft.eissn=1998-3743&rft_id=info:doi/10.4103/0250-474X.100254&rft_dat=%3Cgale_pubme%3EA301924562%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491t-cb22305225c84e40000d0c0181d59603a69bb4be72c1486f51ea1ab16772fdc83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1038803923&rft_id=info:pmid/23112408&rft_galeid=A301924562&rfr_iscdi=true |